Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03154281
Title Evaluation of the Safety and Tolerability of Niraparib With Everolimus in Ovarian and Breast
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Avera McKennan Hospital & University Health Center
Indications

breast cancer

ovarian cancer

Therapies

Everolimus + Niraparib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.